Paratek Pharmaceuticals PRTK

Quarterly report 2023-Q2
added 08-03-2023

Paratek Pharmaceuticals DIO Ratio 2011-2026 | PRTK

Annual DIO Ratio Paratek Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
218	217	614	1.21 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.21 K	217	566

Quarterly DIO Ratio Paratek Pharmaceuticals

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
265	223	-	217	119	310	-	178	103	477	-	658	594	811	-	1.1 K	1.86 K	2.7 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.7 K	103	687

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	FSD Pharma HUGE	174	-	5743.5 %	$ 69.7 M	Canada
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Exelixis EXEL	96.1	$ 48.16	4.22 %	$ 13.1 B	USA
	Fortress Biotech FBIO	210	$ 2.39	-0.42 %	$ 66.7 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	ACADIA Pharmaceuticals ACAD	295	$ 22.4	-0.71 %	$ 3.71 B	USA
	Esperion Therapeutics ESPR	2.46 K	$ 3.14	-	$ 653 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Gilead Sciences GILD	102	$ 131.33	-2.04 %	$ 163 B	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 21.17	2.47 %	$ 2.69 B	USA
	Grifols, S.A. GRFS	0.000171	$ 8.1	0.5 %	$ 5.51 B	Spain